Botox for Migraines Denied by Insurance
Will insurance pay for Botox for migraines?
A plan can deny Botox, onabotulinumtoxinA, when it is prescribed to prevent chronic migraine. The notice may say an approval was missing, that other drugs had to be tried first, that the injection is not medically necessary, or that the plan treats it as cosmetic. The FDA label for Botox says it is indicated for the prophylaxis of headaches in adults with chronic migraine. It says safety and effectiveness have not been established for episodic migraine. Botox Cosmetic is a different product. This page explains the appeal. It does not promise that the plan or Medicare will pay.
Get help with my bill →What should I read on a Botox denial?
The label points below were checked on the FDA prescribing information for Botox and for Botox Cosmetic on November 17, 2026. The denial notice controls the reason and the deadline.
Read the notice for the product name, the dose, the date, and the reason. A missing approval, a requirement to try other drugs first, a decision that the injection is not medically necessary, and a decision that the use is cosmetic are different disputes. HealthCare.gov says preauthorization is a decision that a service is medically necessary, and that it is not a promise of payment. If the notice says approval was missing, see a prior authorization denial. If it says the injection is not medically necessary, see a medical necessity denial. If it says another drug had to be tried first, see a step therapy denial.
The FDA label for Botox, onabotulinumtoxinA, says it is indicated for the prophylaxis of headaches in adult patients with chronic migraine, meaning 15 or more days per month with headache lasting 4 hours a day or longer. The same label says safety and effectiveness have not been established for the prophylaxis of episodic migraine, meaning 14 headache days or fewer per month. The label also says potency units of Botox are not interchangeable with other botulinum toxin preparations. If the denial names a different product, use that product's FDA label. This page is about Botox. Do not change or stop a medicine on your own. Ask the prescriber what to do if a scheduled injection is delayed.
References: HealthCare.gov: Preauthorization · FDA: Botox (onabotulinumtoxinA) prescribing information · HealthCare.gov: Internal appeals
Is Botox for migraine the same as cosmetic Botox?
No. The FDA label for Botox Cosmetic, also onabotulinumtoxinA, says it is indicated in adult patients for the temporary improvement in the appearance of certain moderate to severe facial lines and platysma bands. That label is not the chronic-migraine indication. A plan can deny an injection whose purpose is appearance. Do not describe a treatment for appearance as treatment for migraine, and do not ask anyone to enter a migraine diagnosis the record does not support.
Medicare does not cover cosmetic surgery. 42 CFR 411.15(h) excludes cosmetic surgery and related services, except as required for the prompt repair of accidental injury or to improve the functioning of a malformed body member. Medicare Benefit Policy Manual, Chapter 16, Section 120, says cosmetic surgery includes any surgical procedure directed at improving appearance, except those cases, and except surgery for a therapeutic purpose which coincidentally also serves some cosmetic purpose. A denial that calls a chronic-migraine injection cosmetic should name the product and the policy it used. Ask for both. The therapeutic use on the Botox label is not, by itself, the appearance use on the Botox Cosmetic label.
References: FDA: Botox (onabotulinumtoxinA) prescribing information · FDA: Botox Cosmetic (onabotulinumtoxinA) prescribing information · 42 CFR 411.15: Particular services excluded from Medicare coverage, including cosmetic surgery · Medicare Benefit Policy Manual, Publication 100-02, Chapter 16, Section 120, cosmetic surgery
Will Medicare pay for Botox for chronic migraine?
A Botox injection for migraine is given by a clinician. 42 CFR 410.26 says Part B pays for drugs and biologicals that are not usually self-administered when they are furnished incident to a physician's service in a noninstitutional setting and the other conditions in that section are met. Meeting that description does not, by itself, mean Medicare paid. The claim still has to be reasonable and necessary under the policy the contractor applied.
This page does not cite one national coverage determination that sets chronic-migraine criteria for every state. A Medicare Administrative Contractor may apply a local coverage determination for botulinum toxin. That determination is the medical-necessity rule in that contractor's area. Ask the denial to name it, and ask which criterion it says was missing. Do not use another contractor's criteria as the rule for your claim. 42 CFR 422.101(b) says a Medicare Advantage organization must follow CMS national coverage determinations, general coverage and benefit conditions in traditional Medicare, and written local coverage decisions for the area. The plan's appeal is in how to appeal a Medicare Advantage denial.
42 CFR 423.100 says a drug for which payment is available under Part A or Part B, as prescribed and dispensed or administered, is not a Part D drug. If the notice is a Part D denial, ask whether Part B payment was available for this injection. 42 CFR 423.578(e) says the Part D exceptions process cannot be used for a drug that is not a Part D drug. A pharmacy appeal for a tablet is a different denial. See a prescription drug the plan will not cover.
References: 42 CFR 410.26: Services and supplies incident to a physician's service, including drugs not usually self-administered · 42 CFR 422.101: Medicare Advantage basic benefits, including traditional Medicare coverage criteria · 42 CFR 423.100: Part D drug definition · 42 CFR 423.578: Medicare Part D exceptions process
What if the plan requires other migraine drugs first?
A private plan's written policy may require other preventive drugs before it covers Botox for chronic migraine. That requirement is the plan's policy. This page does not state a number of drugs or a number of months, because a number, when a plan uses one, is in that policy. Ask for the policy. Your prescriber can respond to the criterion it actually states, including a reason a required drug cannot be used. Do not ask anyone to record a trial that did not happen.
Medicare Advantage step therapy for a Part B drug is a specific rule. 42 CFR 422.136 says that if a plan uses step therapy for Part B drugs, it must apply that step therapy only to new administrations, using a lookback of at least 365 days. The protocol may not include a drug the plan does not cover as a Part B drug or, for an MA-PD plan, as a Part D drug. If the notice cites this rule, ask for the lookback it used and for the covered drug it required. The general step-therapy appeal is in a step therapy denial.
References: U.S. Department of Labor: Filing a claim for your health benefits · 42 CFR 422.136: Medicare Advantage step therapy for Part B drugs
How do I appeal a Botox denial?
Use the notice. Ask the prescriber for a letter of medical necessity and the records the policy asks for, including the headache history that matches the reason on the denial. The letter should answer that reason. A letter that only says you need treatment does not answer a specific criterion.
For a private plan, 29 CFR 2560.503-1 gives a group health plan at least 180 days after you receive the denial to appeal, and 45 CFR 147.136 applies that standard to non-grandfathered group and individual coverage. HealthCare.gov says to file within 180 days, and to request an external review in writing within 4 months when the dispute is a medical judgment. If the notice gives a later date, use the notice. For a private-sector workplace health plan, the Department of Labor says an urgent appeal must be decided as soon as your medical needs require, and no later than 72 hours after the plan receives the appeal. A delayed injection is not automatically that urgent appeal. Ask the prescriber whether waiting meets the test, and use the process on the notice. The steps are in how to appeal a health insurance denial and how to request an external review.
For Original Medicare, 42 CFR 405.942 says a redetermination must be filed within 120 calendar days after you receive the notice. Receipt is presumed five calendar days after the date on the notice unless there is evidence otherwise. The steps are in how to appeal an Original Medicare denial. For a Medicare Advantage plan, when the plan grants a request to expedite a Part B drug decision, 42 CFR 422.572 says the decision is due as expeditiously as your health requires and no later than 24 hours after the plan receives the request. Ask whether a clinician's call to the plan is the appeal. It does not move the deadline unless the notice says it does.
References: 29 CFR 2560.503-1: Claims procedure, including the 180-day appeal period · 45 CFR 147.136: Internal claims, appeals, and external review · HealthCare.gov: Internal appeals · HealthCare.gov: External review · U.S. Department of Labor: Filing a claim for your health benefits · 42 CFR 405.942: Original Medicare redetermination filing deadline · Medicare.gov: Appeals in Original Medicare · 42 CFR 422.572: Timeframes for expedited Medicare Advantage organization determinations
What this page cannot promise
This is general information, not medical or legal advice. A plan can require other migraine drugs first. A contractor's local coverage determination can deny an injection that does not meet that contractor's criteria. Cosmetic Botox is a different product, and Medicare does not cover cosmetic surgery. A Part D exception does not cover a drug for which Part B payment is available. An appeal can leave the denial in place. Nothing on this page promises that a plan or Medicare will cover Botox or cancel a bill.
Sources and further help
These sources provide general guidance. For a deadline or requirement that applies to you, follow your plan’s notice or the appropriate program’s current instructions.
- HealthCare.gov: Preauthorization ↗
- HealthCare.gov: Internal appeals ↗
- HealthCare.gov: External review ↗
- U.S. Department of Labor: Filing a claim for your health benefits ↗
- 29 CFR 2560.503-1: Claims procedure, including the 180-day appeal period ↗
- 45 CFR 147.136: Internal claims, appeals, and external review ↗
- FDA: Botox (onabotulinumtoxinA) prescribing information ↗
- FDA: Botox Cosmetic (onabotulinumtoxinA) prescribing information ↗
- 42 CFR 411.15: Particular services excluded from Medicare coverage, including cosmetic surgery ↗
- Medicare Benefit Policy Manual, Publication 100-02, Chapter 16, Section 120, cosmetic surgery ↗
- 42 CFR 410.26: Services and supplies incident to a physician's service, including drugs not usually self-administered ↗
- 42 CFR 423.100: Part D drug definition ↗
- 42 CFR 423.578: Medicare Part D exceptions process ↗
- 42 CFR 422.136: Medicare Advantage step therapy for Part B drugs ↗
- 42 CFR 422.101: Medicare Advantage basic benefits, including traditional Medicare coverage criteria ↗
- 42 CFR 422.572: Timeframes for expedited Medicare Advantage organization determinations ↗
- 42 CFR 405.942: Original Medicare redetermination filing deadline ↗
- Medicare.gov: Appeals in Original Medicare ↗
Insurer websites may ask you to select your state or sign in. If a page will not open, use the member services number on your insurance card and ask for the current appeal instructions for your plan.